"UBE2B" Related Products

Expand
Expand

Recombinant Human UBE2B Protein, His-tagged

Cat.No.: UBE2B-531H
Product Overview: Recombinant Human UBE2B (Accession # NP_003328), fused with an N-terminal 6-His tag, was produced in E. coli.
Source: E. coli
Species: Human
Tag: His
Form: X mg/ml (X µM) in 50 mM HEPES pH 7.5, 200 mM NaCl, 10% Glycerol (v/v), 1 mM TCEP
Bio-activity: Recombinant Human His6-HR6B/UBE2B is a member of the Ubiquitin-conjugating (E2) enzyme family that receives Ubiquitin from a Ubiquitin-activating (E1) enzyme and subsequently interacts with a Ubiquitin ligase (E3) to conjugate Ubiquitin to substrate proteins. Reaction conditions will need to be optimized for each specific application. We recommend an initial Recombinant Human His6-HR6B/UBE2B concentration of 0.1-1 µM.
Molecular Mass: Recombinant Human UBE2B, His-tagged has a calculated MW of 19 kDa.
Purity: >95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain.
Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
Gene Name: UBE2B ubiquitin-conjugating enzyme E2B [ Homo sapiens ]
Official Symbol: UBE2B
Synonyms: UBE2B; ubiquitin-conjugating enzyme E2B; ubiquitin conjugating enzyme E2B (RAD6 homolog); ubiquitin-conjugating enzyme E2 B; HHR6B; RAD6B; UBC2; E2 protein; RAD6 homolog B; ubiquitin-protein ligase B; ubiquitin carrier protein B; ubiquitin-conjugating enzyme E2-17 kDa; ubiquitin-conjugating enzyme E2B (RAD6 homolog); HR6B; E2-17kDa;
Gene ID: 7320
mRNA Refseq: NM_003337
Protein Refseq: NP_003328
MIM: 179095
UniProt ID: P63146
Chromosome Location: 5q31.1

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.